• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Increased neurodegenerative pathology associated with chronic traumatic encephalopathy severity

byDaniel FisherandMichael Milligan
July 28, 2017
in Chronic Disease, Imaging and Intervention, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
Epileptogenic foci may be lateralized using functional brain glutamate imaging
Share on FacebookShare on Twitter

1. In this retrospective study of post-mortem tissue from former American football players, pathological markers of neurodegeneration were frequent in both mild and severe chronic traumatic encephalopathy (CTE) cases but not in those without symptomatic CTE.

2. Increased distributions and quantities of neuropathological markers were associated with increasing CTE severity and broader symptoms.

Evidence Rating Level: 3 (Average)

Study Rundown: Repeated mild traumatic brain injury often leads to a heterogeneous disorder known as chronic traumatic encephalopathy (CTE), typified by a progressive neurodegenerative disease affecting mood, cognition, and motor deficits. In particular, professional American football players are at very high risk of developing this disease, though little is known about the underlying neuropathological mechanisms. In this retrospective study of post-mortem tissue from former American football players, common neuropathological markers of neurodegenerative disease, such as a p-tau, pTDP43, a-synuclein, and amyloid-b aggregations, were highly prevalent and increased with CTE severity. The distribution of these markers in mild CTE were mostly restricted to select cortical areas whereas those with more severe CTE demonstrated multiple cortical and subcortical areas of pathology. Of the 17% of post-mortem tissues without CTE, neuropathology was rare and generally non-specific, and most of these tissues were derived from players who did not reach the professional level. Retrospective, secondary clinical information from standardized informant reports suggest that all CTE cases determined pathologically resulted in mood or cognitive symptoms regardless of disease severity. Motor impairment was apparent in over half of severe CTE patients, and development of both mood and cognitive symptoms was typical as the disease progressed. The most common primary cause of death was neurodegeneration in this cohort.

Though this study suggests a high degree of specific neuropathologies in CTE cases, numerous limitations should be noted. First, lack of a standardized control cohorts makes interpreting the degree neuropathology difficult, and few conclusions should be drawn about impact of these biomarkers on CTE symptoms. Second, the degree of head-trauma could not be calculated, though time spent playing football generally correlated with disease severity, though no strictly quantitative measure was reported. Third, as clinical reports were given second hand, the reliability of these reports is unlikely to be as strong and may overestimate the development of certain symptoms. As this project continues to collect tissue, it will be important to note future results from more controlled studies.

Click to read the study, published in JAMA

RELATED REPORTS

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

2 Minute Medicine Rewind Aug 24th, 2026 

Propofol is associated with lower mortality in sepsis-associated encephalopathy

Relevant Reading: The spectrum of disease in chronic traumatic encephalopathy

In-Depth [retrospective cohort]: 202 former American football players donated post-mortem tissue to the Concussion Legacy Foundation (CLF) and clinical data from secondary sources were compiled into a Federal Interagency Traumatic Brain Injury Research-compliant database. Of the participants, 0% of those with only pre-high school experience developed CTE (0/2 players), 21% with high-school experience (3/14), 91% with college experience (48/53), 64% of semiprofessional (9/14), 88% with Canadian Football League experience (7/8), and 99% with NFL experience (110/111). The median age for those with mild CTE was 44 years (IQR 29-64 years), and the median age for those with severe CTE was 71 years (IQR 64-79 years). The most common cause of death in mild CTE cases was suicide (27%), while the most common cause of death in severe CTE cases was neurodegenerative (47%). Cortical perivascular tau inclusions were detected in all CTE cases mainly in distinct frontal cortical areas with some deposition in the lateral temporal and inferior parietal. By contrast, those with severe CTE also had multiple inclusions in the medial temporal lobe, including in most limbic structures, as well as certain subcortical areas, such as the basal ganglia and thalamus. TDP43 and a-synuclein were common in all CTE cases, while only severe CTE cases tended to have noticeable amyloid-b plaques and angiopathy. Of the 25 participants (17%) without CTE, 9 had no pathology, 7 had nonspecific findings of hemosiderin-laden macrophages or axonal injury, 4 had vascular pathology, 3 had unspecified tauopathy inconsistent with CTE, 2 had Alzheimer’s Disease, 1 had argyrophillic brain disease, and 1 with Lewy Body Disease. Mood symptoms occurred in 96% of mild cases and 89% of severe cases, while cognitive symptoms manifested in 85% of mild and 95% of severe cases. No CTE cases were symptomatic, and 75% of those with severe CTE developed motor impairments.

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic traumatic encephalopathyfootballhead traumaneurocognition
Previous Post

Tocilizumab improves remission rates in giant-cell arteritis: The GiACTA trial

Next Post

Reduction in vaccination rates predicted to increase incidence and cost of measles

RelatedReports

Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Propofol is associated with lower mortality in sepsis-associated encephalopathy

February 11, 2026
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

No difference between pharmacologic treatments in age-related macular degeneration risk reduction

May 8, 2025
Next Post
African American and Hispanic youth more likely to discontinue ADHD treatment

Reduction in vaccination rates predicted to increase incidence and cost of measles

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Genetic variants related to serum calcium levels associated with coronary artery disease

Half of all readmissions following lower respiratory infections occur in infants

Half of all readmissions following lower respiratory infections occur in infants

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.